Medacta positions itself as an innovation-driven orthopedic player with differentiated 3D surgical planning technology and geographic expansion capabilities. The company leverages acquisitions for market penetration, particularly in sports medicine and the ASC (Ambulatory Surgical Center) segment, supported by medical education investments to drive adoption of its surgical solutions.
Cyborg Score Rationale
Medacta demonstrates solid fundamentals with strong revenue growth (18.5% constant-currency growth in 2025), expanding margins (26.63% EBITDA margin), and outperformance versus both industry and market peers. The company benefits from innovative product launches and strategic acquisitions, though its smaller employee base (1,910) limits scale compared to major competitors.
Top Insights
Delivered 18.5% constant-currency revenue growth in 2025, significantly outpacing broader medical device industry trends
Market cap of CHF 3.14B with improving profitability (net income up 71.5% to CHF 56.54M in latest half-year)
Outperformed Swiss Medical Equipment industry return (-21.2%) and Swiss Market (7.3%) over the past year
Strategic focus on geographic expansion and acquisitions in sports medicine and ASC segments with innovative product launches and medical education
Named Competitors
Orthopedic Implants & Surgical Solutions — Global leader in musculoskeletal healthcare with comprehensive orthopedic portfolio
Orthopedic & Surgical Products — Major medical device company with strong orthopedic and surgical segments
Orthopedic & Trauma Solutions — Established player in orthopedic reconstruction and sports medicine
Recent Developments
(February 2026) Reported 18.5% constant-currency revenue growth in 2025 on broad-based demand
(February 2026) Innovation in product launches and medical education expansion driving revenue growth with focus on spine segment and ASCs
(January 2026) Stock reached all-time high of CHF 177.2, up significantly from IPO opening of CHF 104 in April 2019
Open the full interactive Medacta Group SA report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.